Lucid Diligence Brief: Iambic Takeda AI drug discovery collaboration
Lucid Diligence Brief: Iambic Takeda AI drug discovery collaboration…
AI in Healthcare and Digital Health Video Recap—February 9, 2026
This biweekly AI in Healthcare and Digital Health video recap covers major…
Lucid Diligence Brief: Innovent - Eli Lilly Global R&D Alliance
Lucid Diligence Brief: Innovent - Eli Lilly Global R&D Alliance…
AI in Healthcare and Digital Health Today—February 9, 2026
This week's AI in Healthcare and Digital Health update covers key…
Lucid Diligence Brief: uniQure AMT-191 Fabry dosing pause
Lucid Diligence Brief: uniQure AMT-191 Fabry dosing pause Professional…
Lucid Diligence Brief: Angitia Biopharmaceuticals $130 million Series D
Lucid Diligence Brief: Angitia Biopharmaceuticals $130 million Series D…
Lucid Diligence Brief: Eli Lilly Pipeline Rationalization
Lucid Diligence Brief: Eli Lilly Pipeline Rationalization Professional…
Lucid Diligence Brief: Medtronic intent to acquire CathWorks
Lucid Diligence Brief: Medtronic intent to acquire CathWorks Professional…
Lucid Diligence Brief: ZipBio licenses its AI-designed GA AAV program to MeiraGTx
Lucid Diligence Brief: ZipBio licenses its AI-designed GA AAV program to…
Lucid Diligence Brief: Galderma resubmits RelabotulinumtoxinA to the FDA
Lucid Diligence Brief: Galderma resubmits RelabotulinumtoxinA to the FDA…
AI in Healthcare and Digital Health Today—February 2, 2026
This week's AI in Healthcare and Digital Health update highlights AI’s…
Lucid Diligence Brief: Kyowa Kirin regains rocatinlimab rights from Amgen
Lucid Diligence Brief: Kyowa Kirin regains rocatinlimab rights from Amgen…